Previous 10 | Next 10 |
2024-01-05 10:07:14 ET DENVER, Colo., Jan. 5, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Banzai International Inc (NASDAQ: BNZI), Immunic Inc (NASDAQ: IMUX), Dermata Therapeutics (NASDAQ: DRMA), Aino...
2024-01-05 10:00:03 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...
2024-01-05 09:40:51 ET DENVER, Colo., Jan. 5, 2024 ( www.247marketnews.com )- Ainos Inc (NASDAQ: AIMD) has a reported 4.68M shares outstanding and 751.1K shares in its float, so this morning’s premarket action is reason to keep this one on your trading screens. Ainos closed t...
2024-01-02 09:51:47 ET More on Ainos Financial information for Ainos For further details see: Ainos regains compliance with Nasdaq minimum bid price rule
SAN DIEGO, CA / ACCESSWIRE / January 2, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, announced tha...
Mass Production Readiness Targeted for 2H 2024 Propelling AI Nose Technology Towards Broader Industry Adoption and Advancing the Mission of Digitalizing Smell SAN DIEGO, CA / ACCESSWIRE / December 26, 2023 / Ainos, Inc. (NASDAQ: AIMD, AIMDW) ("Ainos", or the "Company"), a diversified hea...
2023-12-12 10:14:16 ET More on Ainos Ainos to issue initial $3M tranche of $10M private placement of notes Financial information for Ainos For further details see: Ainos implements a reverse stock split
SAN DIEGO, CA / ACCESSWIRE / December 12, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos," or the "Company"), a diversified healthcare company focused on the development of AI-powered point-of-care testing, VELDONA® low-dose interferon therapeutics, and synthetic RNA-driven preventative ...
2023-12-08 17:38:23 ET More on Ainos Ainos to issue initial $3M tranche of $10M private placement of notes Financial information for Ainos For further details see: Ainos files to sell 10.2M shares of common stock for holders
Subsequent Phase Involves Completion of Chemistry, Manufacturing, and Controls (CMC) Information Ainos Intends to Submit Investigational New Drug Applications to the U.S. FDA for Multiple Candidates During the First Half of 2024 Candidates include HIV Oral Warts Orphan Drug, Sjogren's S...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...
Clinical trials for AI Nose-powered Ainos Flora device moves forward with 75 meaningful case results, paving the way for next-gen product targeting at-home testing Next-Gen Ainos Flora will advance with NVIDIA CUDA, targeting Q3 for design completion and Q4 for clinical trial kickoff ...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 12.4% to $0.0886 on volume of 1,366,648,994 shares Ascent Solar Technologies Inc (ASTI) rose 63.4% to $0.2147 on volume of 656,794,712 shares Pineapple Energy Inc. (PEGY) rose 61.4% to $...